Search Tag: liver fibrosis

2025 07 May

New research published in the New England Journal of Medicine reveals that semaglutide effectively treats liver disease in nearly two-thirds of patients, offering new hope for those with metabolic dysfunction-associated steatohepatitis (MASH), a severe form of liver disease.   MASH is a progressive form of Metabolic dysfunction-associated steatotic...Read more

2024 30 Nov

  Chronic hepatitis B (CHB) continues to pose significant public health challenges, affecting millions worldwide and leading to substantial morbidity and mortality. One of the most critical aspects of managing CHB is assessing and staging liver fibrosis, which informs treatment decisions and predicts disease progression. Liver biopsy, historically...Read more

2024 20 Oct

  Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is one of the most prevalent chronic liver conditions globally. Its association with metabolic syndrome, including conditions such as obesity, diabetes, and hypertension, makes accurate diagnosis crucial for managing patients...Read more